101110-74-1

Basic information

• Product Name: Benzoic acid, 4-(5-formyl-2-methoxyphenoxy)-, methyl ester
• CAS NO: 101110-74-1
• Molecular Formula: C16H14O5
• Molecular Weight: 286.284
• Mol File: 101110-74-1.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(5-formyl-2-methoxyphenoxy)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(5-formyl-2-methoxyphenoxy)-, methyl ester(101110-74-1)
• EPA Substance Registry System: Benzoic acid, 4-(5-formyl-2-methoxyphenoxy)-, methyl ester(101110-74-1)

Safety Data

• Hazardous Substances Data: 101110-74-1(Hazardous Substances Data)

Upstream product

• 621-59-0 isovanillin 
• 619-42-1 4-methoxycarbonylphenyl bromide 
• 31600-19-8 3-nitro-4-(toluene-4-sulfonyloxy)-benzoic acid methyl ester 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 
• 101274-71-9 4-(5-formyl-2-methoxy-phenoxy)-3-nitro-benzoic acid methyl ester 
• 14719-83-6 methyl 3-nitro-4-chlorobenzoate 
• 109694-35-1 4-(5-diacetoxymethyl-2-methoxy-phenoxy)-3-nitro-benzoic acid methyl ester 
• 59276-36-7 isovanilline dimethyl acetal 

Downstream Products

• 150456-48-7 (E)-1-<4-methoxy-3-(4-methoxycarbonylphenoxy)-phenyl>-but-1-en-3-one 
• 145929-81-3 3-Chloro-4-(5-formyl-2-methoxy-phenoxy)-benzoic acid methyl ester 
• 208399-65-9 4-(5-(1,3-dioxolan-2-yl)-2-methoxyphenoxy)benzaldehyde 
• 208399-64-8 {4-[5-(1,3-dioxolan-2-yl)-2-methoxyphenoxy]phenyl}methanol 
• 208399-71-7 [4-(2-{4-[5-(1,3-dioxolan-2-yl)-2-methoxyphenoxy]phenethyl}-4-methoxyphenyl)-3-methoxyphenyl]methanol 
• 208399-69-3 methyl 4-{2-[2-{4-[5-(1,3-dioxolan-2-yl)-2-methoxyphenoxy]phenyl}-1-ethenyl]-4-methoxyphenyl}-3-methoxybenzoate 
• 208399-70-6 methyl 4-(2-{4-[5-(1,3-dioxolan-2-yl)-2-methoxyphenoxy]phenethyl}-4-methoxyphenyl)-3-methoxybenzoate 

Relevant articles and documents

SYNTHESIS AND STRUCTURE CONFIRMATION OF RICCARDIN B, A MACROCYCLIC BIS(BIBENZYL) FROM THE LIVERWORT, RICCARDIA MULTIFIDA

Riccardin B, a cytotoxic bis(bibenzyl) obtained from a liverwort was synthesized via an intramolecular Wittig-type reaction and the structure was established unequivocally.

Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents

A series of macrocyclic bisbibenzyls with novel skeletons was designed, synthesized, and evaluated for antiproliferative activity against five anthropic cancer cell lines. Among these novel molecules, compound 47 displayed excellent anticancer activity ag

Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity

P-glycoprotein (P-gp) is known to mediate multidrug resistance (MDR) by acting as an efflux pump to actively transport chemotherapeutic agents out of carcinoma cells. Inhibition of P-gp function may represent one of the strategies to reverse MDR. We have